Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
주식 순위 #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
주가
$0.00162013
마지막 동기화: 2025-01-03
시가총액
$156.25K
변동 (1일)
0.36%
변동 (1년)
0.00%
국가
SE
거래 Cyxone AB (publ) (CYXO)

카테고리

Cyxone AB (publ) (CYXO)의 주가 이력
최고 종가: $0.00 (2025-01-01 기준)

최저 종가: $0.50 (2016-06-01 기준)
Cyxone AB (publ)의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2025 -8.09%
2024 -82.58%
2023 -77.33%
2022 -83.86%
2021 -39.25%
2020 12.33%
2019 61.54%
2018 -80.08%
2017 88.25%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE